These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17943419)

  • 1. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.
    Wu L; Bharatwaj B; Panyam J; da Rocha SR
    Pharm Res; 2008 Feb; 25(2):289-301. PubMed ID: 17943419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
    Selvam P; Bharatwaj B; Porcar L; da Rocha SR
    Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential for the noninvasive delivery of polymeric nanocarriers using propellant-based inhalers in the treatment of Chlamydial respiratory infections.
    Bharatwaj B; Wu L; Whittum-Hudson JA; da Rocha SR
    Biomaterials; 2010 Oct; 31(28):7376-85. PubMed ID: 20615546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
    Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
    Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation.
    Wu L; da Rocha SR
    Langmuir; 2007 Nov; 23(24):12104-10. PubMed ID: 17958454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of aerosol clouds produced by pressurised inhalation aerosols.
    Brambilla G; Ganderton D; Garzia R; Lewis D; Meakin B; Ventura P
    Int J Pharm; 1999 Sep; 186(1):53-61. PubMed ID: 10469923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propellant-based inhalers for the non-invasive delivery of genes via oral inhalation.
    Conti DS; Bharatwaj B; Brewer D; da Rocha SR
    J Control Release; 2012 Feb; 157(3):406-17. PubMed ID: 21982899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability.
    Brindley A
    J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.
    Engstrom JD; Tam JM; Miller MA; Williams RO; Johnston KP
    Pharm Res; 2009 Jan; 26(1):101-17. PubMed ID: 18758922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ester group: how hydrofluoroalkane-philic is it?
    Peguin RP; Wu L; da Rocha SR
    Langmuir; 2007 Jul; 23(16):8291-4. PubMed ID: 17602576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-surfactant-propellant interactions in HFA-formulations.
    Vervaet C; Byron PR
    Int J Pharm; 1999 Sep; 186(1):13-30. PubMed ID: 10469920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
    D'Sa D; Chan HK; Chrzanowski W
    Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
    Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
    AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
    Kunka R; Andrews S; Pimazzoni M; Callejas S; Ziviani L; Squassante L; Daley-Yates PT
    Respir Med; 2000 Jun; 94 Suppl B():S10-6. PubMed ID: 10919680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.